HOT TOPICS IN CATHETER-DIRECTED TREATMENTS FOR PULMONARY EMBOLISM

Saturday, March 8, 2025

9:00 AM – 10:00 AM ET

Moderator(s)

Hector M. Garcia-Garcia, MD, PhD

Director of Invasive Imaging Core Laboratory
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.

Panel Discussant(s)

Riyaz Bashir, MD

Director Vascular and Endovascular Medicine
Temple University Hospital
Mount Laurel, NJ, United States

Disclosure(s): Thrombolex: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Jay Giri, MD, MPH

Interventional Cardiologist
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Disclosure(s): Boston Scientifiic: Consultant (Ongoing); Inari Medical: Consultant (Ongoing)
Eric A. Secemsky, MD, MSc

Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure information not submitted.

Disclosure(s):

Riyaz Bashir, MD: Thrombolex: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Jay Giri, MD, MPH: Boston Scientifiic: Consultant (Ongoing); Inari Medical: Consultant (Ongoing)

Eric A. Secemsky, MD, MSc: Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)